Pdt Partners, LLC Akebia Therapeutics, Inc. Transaction History

Pdt Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $312,048 - $1.27 Million	-433,400 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.26 - $3.34 $335,157 - $495,322	-148,300 Reduced 25.49%	433,400 $979,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $6,815 - $11,252	-2,900 Reduced 0.5%	581,700 $1.68 Million
Q2 2021 Aug 16, 2021	SELL	$2.83 - $4.2 $58,015 - $86,100	-20,500 Reduced 3.39%	584,600 $2.22 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.06 $1.77 Million - $3.06 Million	605,100 New	605,100 $2.05 Million

Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $365,899 - $590,444	-67,634 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $57,931 - $98,344	10,748 Added 18.89%	67,634 $374,000
Q3 2018 Nov 14, 2018	BUY	$7.44 - $10.65 $423,231 - $605,835	56,886 New	56,886 $502,000

127

56.7M

937K

743K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $188M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.